APO Research
Talk to an analyst

APO RESEARCH · REPORT

Immunology Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Immunology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025199 pages

Choose your research edition.

Industry ResearchImmunology Drug Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Immunology Drug Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Immunology Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Immunology Drug Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Immunology Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Immunology Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Immunology Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Immunology Drug include Eisai Co., Eli Lilly and Company, Pfizer, GlaxoSmithKline plc, Bayer AG, Seattle Genetics, Sanofi Aventis LLC., Genentech and F. Hoffmann-La Roche Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Immunology Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Immunology Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Immunology Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Immunology Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Immunology Drug Segment by Company

Eisai Co.

Eli Lilly and Company

Pfizer

GlaxoSmithKline plc

Bayer AG

Seattle Genetics

Sanofi Aventis LLC.

Genentech

F. Hoffmann-La Roche Ltd.

Autoimmune Inc.

Active Biotech

Abbott Laboratories

Immunology Drug Segment by Type

Monoclonal Antibodies (mAb)

Antibody Drug Conjugates

Immunosuppressive medication

Others

Immunology Drug Segment by Application

Cancer Research Centers and Institutes

Hospitals

Clinics

Immunology Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Immunology Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Immunology Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Immunology Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Immunology Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Immunology Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Immunology Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Immunology Drug Industry Trends Table 2. Immunology Drug Industry Drivers Table 3. Immunology Drug Industry Opportunities and Challenges Table 4. Immunology Drug Industry Restraints Table 5. Global Immunology Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Immunology Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Immunology Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Immunology Drug Sales Market Share by Manufacturers Table 9. Global Immunology Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Immunology Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Immunology Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Immunology Drug Manufacturers, Product Type & Application Table 13. Global Immunology Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Immunology Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Monoclonal Antibodies (mAb) Table 17. Major Manufacturers of Antibody Drug Conjugates Table 18. Major Manufacturers of Immunosuppressive medication Table 19. Major Manufacturers of Others Table 20. Global Immunology Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 21. Global Immunology Drug Sales by Type (2021-2026) & (K Units) Table 22. Global Immunology Drug Sales by Type (2027-2032) & (K Units) Table 23. Global Immunology Drug Sales Market Share by Type (2021-2026) Table 24. Global Immunology Drug Sales Market Share by Type (2027-2032) Table 25. Global Immunology Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 26. Global Immunology Drug Revenue by Type (2021-2026) & (K Units) Table 27. Global Immunology Drug Revenue by Type (2027-2032) & (K Units) Table 28. Global Immunology Drug Revenue Market Share by Type (2021-2026) Table 29. Global Immunology Drug Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Cancer Research Centers and Institutes Table 31. Major Manufacturers of Hospitals Table 32. Major Manufacturers of Clinics Table 33. Global Immunology Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 34. Global Immunology Drug Sales by Application (2021-2026) & (K Units) Table 35. Global Immunology Drug Sales by Application (2027-2032) & (K Units) Table 36. Global Immunology Drug Sales Market Share by Application (2021-2026) Table 37. Global Immunology Drug Sales Market Share by Application (2027-2032) Table 38. Global Immunology Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Immunology Drug Revenue by Application (2021-2026) & (K Units) Table 40. Global Immunology Drug Revenue by Application (2027-2032) & (K Units) Table 41. Global Immunology Drug Revenue Market Share by Application (2021-2026) Table 42. Global Immunology Drug Revenue Market Share by Application (2027-2032) Table 43. Global Immunology Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 44. Global Immunology Drug Sales by Region (2021-2026) & (K Units) Table 45. Global Immunology Drug Sales Market Share by Region (2021-2026) Table 46. Global Immunology Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 47. Global Immunology Drug Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. North America Immunology Drug Sales by Country (2021-2026) & (K Units) Table 50. North America Immunology Drug Sales by Country (2027-2032) & (K Units) Table 51. Europe Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Europe Immunology Drug Sales by Country (2021-2026) & (K Units) Table 53. Europe Immunology Drug Sales by Country (2027-2032) & (K Units) Table 54. Asia Pacific Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Asia Pacific Immunology Drug Sales by Country (2021-2026) & (K Units) Table 56. Asia Pacific Immunology Drug Sales by Country (2027-2032) & (K Units) Table 57. South America, Middle East and Africa Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. South America, Middle East and Africa Immunology Drug Sales by Country (2021-2026) & (K Units) Table 59. South America, Middle East and Africa Immunology Drug Sales by Country (2027-2032) & (K Units) Table 60. Global Immunology Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Immunology Drug Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Immunology Drug Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Immunology Drug Revenue Market Share by Region (2021-2026) Table 64. Global Immunology Drug Revenue Market Share by Region (2027-2032) Table 65. Eisai Co. Company Information Table 66. Eisai Co. Business Overview Table 67. Eisai Co. Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Eisai Co. Immunology Drug Product Portfolio Table 69. Eisai Co. Recent Development Table 70. Eli Lilly and Company Company Information Table 71. Eli Lilly and Company Business Overview Table 72. Eli Lilly and Company Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Eli Lilly and Company Immunology Drug Product Portfolio Table 74. Eli Lilly and Company Recent Development Table 75. Pfizer Company Information Table 76. Pfizer Business Overview Table 77. Pfizer Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Pfizer Immunology Drug Product Portfolio Table 79. Pfizer Recent Development Table 80. GlaxoSmithKline plc Company Information Table 81. GlaxoSmithKline plc Business Overview Table 82. GlaxoSmithKline plc Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. GlaxoSmithKline plc Immunology Drug Product Portfolio Table 84. GlaxoSmithKline plc Recent Development Table 85. Bayer AG Company Information Table 86. Bayer AG Business Overview Table 87. Bayer AG Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Bayer AG Immunology Drug Product Portfolio Table 89. Bayer AG Recent Development Table 90. Seattle Genetics Company Information Table 91. Seattle Genetics Business Overview Table 92. Seattle Genetics Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Seattle Genetics Immunology Drug Product Portfolio Table 94. Seattle Genetics Recent Development Table 95. Sanofi Aventis LLC. Company Information Table 96. Sanofi Aventis LLC. Business Overview Table 97. Sanofi Aventis LLC. Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Sanofi Aventis LLC. Immunology Drug Product Portfolio Table 99. Sanofi Aventis LLC. Recent Development Table 100. Genentech Company Information Table 101. Genentech Business Overview Table 102. Genentech Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Genentech Immunology Drug Product Portfolio Table 104. Genentech Recent Development Table 105. F. Hoffmann-La Roche Ltd. Company Information Table 106. F. Hoffmann-La Roche Ltd. Business Overview Table 107. F. Hoffmann-La Roche Ltd. Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio Table 109. F. Hoffmann-La Roche Ltd. Recent Development Table 110. Autoimmune Inc. Company Information Table 111. Autoimmune Inc. Business Overview Table 112. Autoimmune Inc. Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Autoimmune Inc. Immunology Drug Product Portfolio Table 114. Autoimmune Inc. Recent Development Table 115. Active Biotech Company Information Table 116. Active Biotech Business Overview Table 117. Active Biotech Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Active Biotech Immunology Drug Product Portfolio Table 119. Active Biotech Recent Development Table 120. Abbott Laboratories Company Information Table 121. Abbott Laboratories Business Overview Table 122. Abbott Laboratories Immunology Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Abbott Laboratories Immunology Drug Product Portfolio Table 124. Abbott Laboratories Recent Development Table 125. Key Raw Materials Table 126. Raw Materials Key Suppliers Table 127. Immunology Drug Distributors List Table 128. Immunology Drug Customers List Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Immunology Drug Product Image Figure 2. Global Immunology Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Immunology Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Immunology Drug Sales (2021-2032) & (K Units) Figure 5. Global Immunology Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Immunology Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Monoclonal Antibodies (mAb) Image Figure 9. Antibody Drug Conjugates Image Figure 10. Immunosuppressive medication Image Figure 11. Others Image Figure 12. Global Immunology Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 13. Global Immunology Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Immunology Drug Sales Market Share by Type (2021-2032) Figure 15. Global Immunology Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Immunology Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Immunology Drug Revenue Market Share by Type (2021-2032) Figure 18. Cancer Research Centers and Institutes Image Figure 19. Hospitals Image Figure 20. Clinics Image Figure 21. Global Immunology Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Immunology Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Immunology Drug Sales Market Share by Application (2021-2032) Figure 24. Global Immunology Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Immunology Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Immunology Drug Revenue Market Share by Application (2021-2032) Figure 27. North America Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 28. North America Immunology Drug Sales Market Share by Country (2021-2032) Figure 29. U.S. Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Canada Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Mexico Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Immunology Drug Sales Market Share by Country (2021-2032) Figure 34. Germany Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. France Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. U.K. Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Italy Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Netherlands Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Immunology Drug Sales Market Share by Country (2021-2032) Figure 41. China Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Japan Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. South Korea Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Southeast Asia Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. India Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. Australia Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Immunology Drug Sales Market Share by Country (2021-2032) Figure 49. Brazil Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South Africa Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Saudi Arabia Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Turkey Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Argentina Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. UAE Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Egypt Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Chile Immunology Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Global Immunology Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Immunology Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Immunology Drug Revenue (2021-2032) & (US$ Million) Figure 60. North America Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Immunology Drug Revenue (2021-2032) & (US$ Million) Figure 62. Europe Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Immunology Drug Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Immunology Drug Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Immunology Drug Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Immunology Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Monoclonal Antibodies (mAb)
  • Antibody Drug Conjugates
  • Immunosuppressive medication
  • Others
Applications
  • Cancer Research Centers and Institutes
  • Hospitals
  • Clinics
Companies covered
  • Eisai Co.
  • Eli Lilly and Company
  • Pfizer
  • GlaxoSmithKline plc
  • Bayer AG
  • Seattle Genetics
  • Sanofi Aventis LLC.
  • Genentech
  • F. Hoffmann-La Roche Ltd.
  • Autoimmune Inc.
  • Active Biotech
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Immunology Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Immunology Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Immunology Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Immunology Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Immunology Drug Market Dynamics
  1. 2.1 Immunology Drug Industry Trends
  2. 2.2 Immunology Drug Industry Drivers
  3. 2.3 Immunology Drug Industry Opportunities and Challenges
  4. 2.4 Immunology Drug Industry Restraints
3 Immunology Drug Market by Manufacturers
  1. 3.1 Global Immunology Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Immunology Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Immunology Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Immunology Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Immunology Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Immunology Drug Manufacturers, Product Type & Application
  7. 3.7 Global Immunology Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Immunology Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Immunology Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Immunology Drug Tier 1, Tier 2, and Tier 3
4 Immunology Drug Market by Type
  1. 4.1 Immunology Drug Type Introduction
  2. 4.1.1 Monoclonal Antibodies (mAb)
  3. 4.1.2 Antibody Drug Conjugates
  4. 4.1.3 Immunosuppressive medication
  5. 4.1.4 Others
  6. 4.2 Global Immunology Drug Sales by Type
  7. 4.2.1 Global Immunology Drug Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Immunology Drug Sales by Type (2021-2032)
  9. 4.2.3 Global Immunology Drug Sales Market Share by Type (2021-2032)
  10. 4.3 Global Immunology Drug Revenue by Type
  11. 4.3.1 Global Immunology Drug Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Immunology Drug Revenue by Type (2021-2032)
  13. 4.3.3 Global Immunology Drug Revenue Market Share by Type (2021-2032)
5 Immunology Drug Market by Application
  1. 5.1 Immunology Drug Application Introduction
  2. 5.1.1 Cancer Research Centers and Institutes
  3. 5.1.2 Hospitals
  4. 5.1.3 Clinics
  5. 5.2 Global Immunology Drug Sales by Application
  6. 5.2.1 Global Immunology Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Immunology Drug Sales by Application (2021-2032)
  8. 5.2.3 Global Immunology Drug Sales Market Share by Application (2021-2032)
  9. 5.3 Global Immunology Drug Revenue by Application
  10. 5.3.1 Global Immunology Drug Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Immunology Drug Revenue by Application (2021-2032)
  12. 5.3.3 Global Immunology Drug Revenue Market Share by Application (2021-2032)
6 Global Immunology Drug Sales by Region
  1. 6.1 Global Immunology Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Immunology Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Immunology Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Immunology Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Immunology Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Immunology Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Immunology Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Immunology Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Immunology Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Immunology Drug Revenue by Region
  1. 7.1 Global Immunology Drug Revenue by Region
  2. 7.1.1 Global Immunology Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Immunology Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Immunology Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Immunology Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Immunology Drug Revenue (2021-2032)
  8. 7.2.2 North America Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Immunology Drug Revenue (2021-2032)
  11. 7.3.2 Europe Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Immunology Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Immunology Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Immunology Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Eisai Co.
  2. 8.1.1 Eisai Co. Company Information
  3. 8.1.2 Eisai Co. Business Overview
  4. 8.1.3 Eisai Co. Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Eisai Co. Immunology Drug Product Portfolio
  6. 8.1.5 Eisai Co. Recent Developments
  7. 8.2 Eli Lilly and Company
  8. 8.2.1 Eli Lilly and Company Company Information
  9. 8.2.2 Eli Lilly and Company Business Overview
  10. 8.2.3 Eli Lilly and Company Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Company Immunology Drug Product Portfolio
  12. 8.2.5 Eli Lilly and Company Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Immunology Drug Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 GlaxoSmithKline plc
  20. 8.4.1 GlaxoSmithKline plc Company Information
  21. 8.4.2 GlaxoSmithKline plc Business Overview
  22. 8.4.3 GlaxoSmithKline plc Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 GlaxoSmithKline plc Immunology Drug Product Portfolio
  24. 8.4.5 GlaxoSmithKline plc Recent Developments
  25. 8.5 Bayer AG
  26. 8.5.1 Bayer AG Company Information
  27. 8.5.2 Bayer AG Business Overview
  28. 8.5.3 Bayer AG Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer AG Immunology Drug Product Portfolio
  30. 8.5.5 Bayer AG Recent Developments
  31. 8.6 Seattle Genetics
  32. 8.6.1 Seattle Genetics Company Information
  33. 8.6.2 Seattle Genetics Business Overview
  34. 8.6.3 Seattle Genetics Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Seattle Genetics Immunology Drug Product Portfolio
  36. 8.6.5 Seattle Genetics Recent Developments
  37. 8.7 Sanofi Aventis LLC.
  38. 8.7.1 Sanofi Aventis LLC. Company Information
  39. 8.7.2 Sanofi Aventis LLC. Business Overview
  40. 8.7.3 Sanofi Aventis LLC. Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanofi Aventis LLC. Immunology Drug Product Portfolio
  42. 8.7.5 Sanofi Aventis LLC. Recent Developments
  43. 8.8 Genentech
  44. 8.8.1 Genentech Company Information
  45. 8.8.2 Genentech Business Overview
  46. 8.8.3 Genentech Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Genentech Immunology Drug Product Portfolio
  48. 8.8.5 Genentech Recent Developments
  49. 8.9 F. Hoffmann-La Roche Ltd.
  50. 8.9.1 F. Hoffmann-La Roche Ltd. Company Information
  51. 8.9.2 F. Hoffmann-La Roche Ltd. Business Overview
  52. 8.9.3 F. Hoffmann-La Roche Ltd. Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 F. Hoffmann-La Roche Ltd. Immunology Drug Product Portfolio
  54. 8.9.5 F. Hoffmann-La Roche Ltd. Recent Developments
  55. 8.10 Autoimmune Inc.
  56. 8.10.1 Autoimmune Inc. Company Information
  57. 8.10.2 Autoimmune Inc. Business Overview
  58. 8.10.3 Autoimmune Inc. Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Autoimmune Inc. Immunology Drug Product Portfolio
  60. 8.10.5 Autoimmune Inc. Recent Developments
  61. 8.11 Active Biotech
  62. 8.11.1 Active Biotech Company Information
  63. 8.11.2 Active Biotech Business Overview
  64. 8.11.3 Active Biotech Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Active Biotech Immunology Drug Product Portfolio
  66. 8.11.5 Active Biotech Recent Developments
  67. 8.12 Abbott Laboratories
  68. 8.12.1 Abbott Laboratories Company Information
  69. 8.12.2 Abbott Laboratories Business Overview
  70. 8.12.3 Abbott Laboratories Immunology Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Abbott Laboratories Immunology Drug Product Portfolio
  72. 8.12.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Immunology Drug Value Chain Analysis
  2. 9.1.1 Immunology Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Immunology Drug Production Mode & Process
  6. 9.2 Immunology Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Immunology Drug Distributors
  9. 9.2.3 Immunology Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst